期刊
EMBO JOURNAL
卷 23, 期 20, 页码 4096-4105出版社
WILEY
DOI: 10.1038/sj.emboj.7600415
关键词
neuroinflammation; neuronal degeneration; NF-kappa B activation; synaptic plasticity
资金
- NIA NIH HHS [K07 AG000959, AG16223, AG60901, R01 AG018345, AG18345, AG17490, P01 AG017490, 1KO7AG00959] Funding Source: Medline
- CSR NIH HHS [IIRG-00-2076] Funding Source: Medline
Receptor for Advanced Glycation Endproducts (RAGE), a multiligand receptor in the immunoglobulin superfamily, functions as a signal-transducing cell surface acceptor for amyloid-beta peptide (Abeta). In view of increased neuronal expression of RAGE in Alzheimer's disease, a murine model was developed to assess the impact of RAGE in an Ab-rich environment, employing transgenics (Tgs) with targeted neuronal overexpression of RAGE and mutant amyloid precursor protein (APP). Double Tgs (mutant APP (mAPP)/RAGE) displayed early abnormalities in spatial learning/memory, accompanied by altered activation of markers of synaptic plasticity and exaggerated neuropathologic findings, before such changes were found in mAPP mice. In contrast, Tg mice bearing a dominant-negative RAGE construct targeted to neurons crossed with mAPP animals displayed preservation of spatial learning/memory and diminished neuropathologic changes. These data indicate that RAGE is a cofactor for Abeta-induced neuronal perturbation in a model of Alzheimer's-type pathology, and suggest its potential as a therapeutic target to ameliorate cellular dysfunction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据